145 related articles for article (PubMed ID: 32773415)
1. Hydroxychloroquine for chemoprophylaxis in COVID-19: A case of motivated perception?
Manjunath BG; Tyagi D; Chaudhry D; Singh PK
Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):116-118. PubMed ID: 32773415
[No Abstract] [Full Text] [Related]
2. Hydroxychloroquine prophylaxis for SARS-CoV-2 infection among healthcare workers.
R Karim HM; Ahmed G
Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):119-120. PubMed ID: 32773410
[No Abstract] [Full Text] [Related]
3. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
Avidan MS; Dehbi HM; Delany-Moretlwe S
N Engl J Med; 2020 Sep; 383(11):1087-1088. PubMed ID: 32668106
[No Abstract] [Full Text] [Related]
4. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
Tekwani BL
N Engl J Med; 2020 Sep; 383(11):1088-1089. PubMed ID: 32668108
[No Abstract] [Full Text] [Related]
5. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
Khan MS; Butler J
N Engl J Med; 2020 Sep; 383(11):1088. PubMed ID: 32668107
[No Abstract] [Full Text] [Related]
6. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. Reply.
Okafor EC; Pastick KA; Rajasingham R
N Engl J Med; 2020 Sep; 383(11):1089. PubMed ID: 32668109
[No Abstract] [Full Text] [Related]
7. Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment?
Patrì A; Fabbrocini G
J Am Acad Dermatol; 2020 Jun; 82(6):e221. PubMed ID: 32283237
[No Abstract] [Full Text] [Related]
8. Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach.
Tilangi P; Desai D; Khan A; Soneja M
Lancet Infect Dis; 2020 Oct; 20(10):1119-1120. PubMed ID: 32450054
[No Abstract] [Full Text] [Related]
9. Could Chloroquine /Hydroxychloroquine Be Harmful in Coronavirus Disease 2019 (COVID-19) Treatment?
Guastalegname M; Vallone A
Clin Infect Dis; 2020 Jul; 71(15):888-889. PubMed ID: 32211771
[No Abstract] [Full Text] [Related]
10. The Saga of Hydroxychloroquine and COVID-19: A Cautionary Tale.
Schluger NW
Ann Intern Med; 2020 Oct; 173(8):662-663. PubMed ID: 32673059
[TBL] [Abstract][Full Text] [Related]
11. Optimal dosing & time: Issues to get hydroxychloroquine safety & efficacy against COVID-19/SARS-CoV-2.
Neves FS
Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):124-126. PubMed ID: 32801224
[No Abstract] [Full Text] [Related]
12. Experience of short-term hydroxychloroquine and azithromycin in COVID-19 patients and effect on QTc trend.
Hor CP; Hussin N; Nalliah S; Ooi WT; Tang XY; Zachariah S; Jugindar Singh GPS; Abdul Rani R; Perumal K; Cheah WK
J Infect; 2020 Aug; 81(2):e117-e119. PubMed ID: 32474031
[No Abstract] [Full Text] [Related]
13. Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen.
Pareek A; Bhandari S; Mehta RT
Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):130-132. PubMed ID: 32811798
[No Abstract] [Full Text] [Related]
14. The impact of hydroxychloroquine shortages on patients with dermatological conditions during COVID-19 pandemic.
Shah M; Sachdeva M; Dodiuk-Gad RP
Dermatol Ther; 2020 Jul; 33(4):e13524. PubMed ID: 32383251
[No Abstract] [Full Text] [Related]
15. Update Alert 2: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19.
Hernandez AV; Roman YM; Pasupuleti V; Barboza JJ; White CM
Ann Intern Med; 2020 Oct; 173(7):W128-W129. PubMed ID: 32853033
[No Abstract] [Full Text] [Related]
16. Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19).
Gao J; Hu S
Biosci Trends; 2020 May; 14(2):156-158. PubMed ID: 32281583
[TBL] [Abstract][Full Text] [Related]
17. A Word of Caution in the Use of Hydroxychloroquine in the Elderly COVID-19 Population.
Martinez Navarro W; Ly L; Segal MS; Shukla AM
Asia Pac J Ophthalmol (Phila); 2020; 9(4):374-375. PubMed ID: 32740071
[No Abstract] [Full Text] [Related]
18. Chloroquine and Hydroxychloroquine in COVID-19: Challenges and the Need for Caution in Low-Resource Settings.
Islam M
J Coll Physicians Surg Pak; 2020 Jun; 30(6):78. PubMed ID: 32723461
[No Abstract] [Full Text] [Related]
19. Hydroxychloroquine-azithromycin for COVID-19 - Warranted or dangerous?
Popescu CP; Fischer PR
Travel Med Infect Dis; 2020; 35():101764. PubMed ID: 32485391
[No Abstract] [Full Text] [Related]
20. Update Alert 2: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians.
Qaseem A; Yost J; Etxeandia-Ikobaltzeta I; Humphrey LL
Ann Intern Med; 2020 Sep; 173(5):W88-W89. PubMed ID: 32730105
[No Abstract] [Full Text] [Related]
[Next] [New Search]
